Midgard Science

Novoheart

Hong Kong, Hong Kong SAR China novoheart.com From their website, Nov 2026

Work here? Claim this listing

About

Novoheart develops bioengineered human heart constructs for drug discovery, disease modeling, and screening. It serves researchers and drug developers working on cardiac therapeutics, with laboratory locations in Boston, Hong Kong, and a Singapore facility coming soon.

Services

  • Human embryonic or induced pluripotent stem cell differentiation to ventricular cardiomyoc

    Differentiates pluripotent stem cells into ventricular cardiomyocytes.

  • Mini-Heart engineered tissue assays using specified cell lines

    Provides engineered human heart tissue assays built from specified cell lines.

  • Human Ventricular Cardiac Anisotropic Sheet (hvCAS)

    Offers anisotropic sheet assays for cardiac modeling and testing.

  • Human Ventricular Cardiac Tissue Strip (hvCTS)

    Offers tissue strip assays for contractility and related cardiac functional testing.

  • Human Heart-in-a-Jar™ / Human Ventricular Cardiac Organoid Chamber (hvCOC)

    Provides a human heart-in-a-jar organoid chamber model for testing toxicity and efficacy.

  • Drug discovery

    Supports drug discovery using human-specific cardiac models.

  • Cardiotoxicity screening

    Screens compounds for cardiac toxicity.

  • Disease modeling of rare/genetic and acquired heart diseases

    Builds disease models for rare, genetic, and acquired heart diseases.

5 more services
  • Efficacy studies
  • Dose titration and optimization
  • Patient cohort-specific responses to drug treatments
  • Screening and phenotyping services
  • Research and development / consultation related to new disease models and therapeutics

Capabilities

Assays and studies
  • Patch clamp
  • Electrophysiology
  • Arrhythmia
  • Contractility
  • Pressure-volume
  • Toxicity
5 more
  • Efficacy
  • Screening
  • Phenotyping
  • Dose response
  • Cardiotoxicity
Therapeutic areas
  • Heart disease
  • Cardiac therapeutics
  • Drug discovery

Instruments and platforms

  • CTScreen System Software
  • Mini-Heart T-Monitor
  • Mini-Heart T-Processor
  • Mini-Heart T-Analyzer

Modalities and species

Modalities
Gene and cell products
Species and models
  • Human pluripotent stem cells
  • Human embryonic stem cells
  • Human induced pluripotent stem cells
  • Human ventricular cardiomyocytes
  • Heart failure with preserved ejection fraction
  • COVID
3 more
  • Arrhythmias
  • Long QT Syndrome
  • Friedreich's Ataxia

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Founded
2014
Office
6 Tide Street, 2nd Floor, Boston, MA 02210, USA
Sites
Boston, USA
Serves
Global

Public records

Parent company
Novoheart Holdings Inc. · CA GLEIF

Similar labs